USE OF IMMUNOMODULATORS IN CHEMOTHERAPY, MORPHOLOGICAL AND BIOCHEMICAL CHANGES IN THE KIDNEYS

Abstract

The use of chemotherapy for breast cancer is immunotherapy. The main objectives of immunotherapy for breast cancer are to stop or slow down the growth of the primary tumor and metastases, prevent metastasis and recurrence after surgery, and increase the effectiveness of other treatments. The greatest nephrotoxicity among the above are alkylating drugs and antimetabolites. In addition to cytostatic agents, various types of accompanying therapy in cancer patients. The use of immunomodulation during chemotherapy has a positive effect on kidney damage.